Related content

Retigabine/Ezogabine, a KCNQ/K_V7 channel opener: pharmacological and clinical data

By Orhan Gökce   Wuttke Thomas V   Nies Anne T   Schwab Matthias   Lerche Holger  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1807-1816

Informa Healthcare

Access to resources Recommend Favorite

Recent Developments on KCNQ Potassium Channel Openers

By  

Current Medicinal Chemistry, Vol. 12, Iss. 4, 2005-02 ,pp. : 453-460

Bentham Science Publishers

Access to resources Recommend Favorite

The Kv7 potassium channel activator retigabine decreases alcohol consumption in rats

By Knapp Clifford M.   O’Malley Matthew   Datta Subimal   Ciraulo Domenic A.  

The American Journal of Drug and Alcohol Abuse, Vol. 40, Iss. 3, 2014-05 ,pp. : 244-250

Informa Healthcare

Access to resources Recommend Favorite

Anti-Ulcer Activity of Skp-450, a Novel Potassium Channel Activator, in Rats

By Cheon H.G.Y.E.O.N.G.   Kim H.J.U.N.G.   Mo H.K.Y.O.U.N.G.   Yoo S.E.U.N.   Lee B.H.O.  

Pharmacological Research, Vol. 40, Iss. 3, 1999-09 ,pp. : 243-248

Academic Press

Access to resources Recommend Favorite

Novel Piperazinyl Derivatives with Anti-Hyperalgesic, Anti-Allodynic and Anti-Inflammatory activities Useful for the Treatment of Neuropathic Pain

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 11, Iss. 2, 2012-09 ,pp. : 182-190

Bentham Science Publishers

Access to resources Recommend Favorite